
Wayfinder Biosciences
Wayfinder Biosciences develops RNA-targeting small molecules for undruggable targets.
About Wayfinder Biosciences
Recent Funding lists Wayfinder Biosciences under Health and bio. It went through IndieBio (IndieBio SF 12). It was founded by Jason Fontana, David Sparkman-Yager and Chuhern Hwang.
Funding rounds
- IndieBio SF 12
IIndieBio · batchSource: indiebio.co - Website created
Founders and team
JF
Jason Fontana Founder & CEOsource: wayfinderbio.comDS
David Sparkman-Yager Founder & CTOsource: wayfinderbio.comCH
Chuhern Hwang Founder & Head of Drug Discoverysource: wayfinderbio.com
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
Wayfinder Biosciences: questions and answers
- Who invested in Wayfinder Biosciences?
- Investors on record for Wayfinder Biosciences: IndieBio.
- Who founded Wayfinder Biosciences?
- Wayfinder Biosciences was founded by Jason Fontana (Founder & CEO), David Sparkman-Yager (Founder & CTO) and Chuhern Hwang (Founder & Head of Drug Discovery).
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/wayfinder-biosciences (get a free API key).